最新动态:
当前位置:中国抗衰老网 >> 新闻系统 >> 饮食抗衰 >> 浏览文章

Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.

时间:2014年11月16日 信息来源:互联网 点击:

基因修饰T细胞帮助免疫体系攻击肿瘤

        Translating the recent success of chimeric antigen receptor (CAR) T cell therapy for hematological malignancies to solid tumors will necessitate overcoming several obstacles, including inefficient T cell tumor infiltration and insufficient functional persistence. Taking advantage of an orthotopic model that faithfully mimics human pleural malignancy, we evaluated two routes of administration of mesothelin-targeted T cells using the M28z CAR. We found that intrapleurally administered CAR T cells vastly outperformed systemically infused T cells, requiring 30-fold fewer M28z T cells to induce long-term complete remissions. After intrapleural T cell administration, prompt in vivo antigen-induced T cell activation allowed robust CAR T cell expansion and effector differentiation, resulting in enhanced antitumor efficacy and functional T cell persistence for 200 days. Regional T cell administration also promoted efficient elimination of extrathoracic tumor sites. This therapeutic efficacy was dependent on early CD4(+) T cell activation associated with a higher intratumoral CD4/CD8 cell ratios and CD28-dependent CD4(+) T cell-mediated cytotoxicity. In contrast, intravenously delivered CAR T cells, even when accumulated at equivalent numbers in the pleural tumor, did not achieve comparable activation, tumor eradication, or persistence. The ability of intrapleurally administered T cells to circulate and persist supports the concept of delivering optimal CAR T cell therapy through "regional distribution centers." On the basis of these results, we are opening a phase 1 clinical trial to evaluate the safety of intrapleural administration of mesothelin-targeted CAR T cells in patients with primary or secondary pleural malignancies.

 


上一篇:吃啥药吃啥菜吃啥饭你可能不懂
下一篇:究竟喝咖啡照旧喝茶如何选择?
作者:互联网; 编辑:admin
关于我们 |联系我们 |欢迎合作 |隐私声明 |版权与著作权 |网站地图 |域名出售 | 广告服务 | 友情链接
联系电话:13802268531 或 0755-83991158 邮箱:1456359608@qq.com
世界杰出华商协会医疗器械商会 全国健康工作委员会抗衰老专业委员会 联合主办
投稿、提意见、主编信箱:wnsn8899#126.com(发送时#改为@)
 
《中华人民共和国电信与信息服务业务经营许可证》编号:粤ICP备 07010450号   Design by: LXHD.CN